Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
THX, I hope it works
According to has had slaps on the wrist, but I wouldn’t expect it to impact their priority. Accord has received FDA approval as recently as April:
https://www.pharmaceutical-technology.com/news/accord-biopharma-hercessi-approval/#:~:text=Accord%20BioPharma%2C%20the%20speciality%20division,to%20treat%20HER2%2Doverexpressing%20cancers.
Ofcourse they can have it made here, but I thought it might be a stumbling block if they have to relocate back to the USA, that is, paper work, inspections, etc.
Also, they may run into a catch 22
Hi sharkey1 , Accord is still very much in business in the USA. It is true that they have had FDA issues, but those issues have not put them out of business. https://www.accordhealthcare.us/about/#:~:text=Our%20U.S.%20headquarters%20is%20in,research%20parks%20in%20the%20world. That said, I agree that the patent ruling is a huge positive for Elite. If Elite is second to market with a generic OxyContin it still will be a needle mover for the company.
This, I believe to be the latest on the Purdue patent, the rest is behind a pay wall
The bankrupt Purdue Pharma lost its legal effort to use patent laws to block an Indian drugmaker from launching a generic version of OxyContin when a federal judge in Delaware decided on Tuesday that some of the patents covering the drug's newer "abuse-deterrent" features could be found in decade-old academic articles and patent paperwork.
Now, we all know the Indian drug maker is an off shoot of Accord, and that facility got hit last year with a huge
warning letter and was almost shut down, or not allowed to send drugs to the USA till they clean up their act.
So, if that's where Accord want's to make their Generic OxyContin, they are DOA, witch makes Elite first to file.
Great bar chart summation!
Thanks for the post;
Hey, join us over here, without that demented Imbecile. (I'll explain more later)
https://investorshub.advfn.com/Analyst-forum-for-Bitcoin-43198
ap
For a tip. 10c
If you sold at 15 why do you care ?
Are you hanging in for a dip to re enter ?
https://www.tradingview.com/symbols/OTC-ELTP/
https://corporatefinanceinstitute.com/resources/career-map/sell-side/capital-markets/volume-price-trend-indicator-vpt/
Here are some key points about how volume trends may impact the future direction of Elite Pharmaceuticals:
Increasing volume on price movements is generally seen as confirming the trend. "Elite Pharmaceuticals Inc has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation."
The Volume Price Trend (VPT) indicator can be used to assess the balance between supply and demand for a stock. Rising VPT values along with rising prices would indicate strong bullish momentum for ELTP.
Volume spikes can sometimes signal exhaustion of a trend. However, for ELTP, the volume increase seems to be confirming the upward price movement rather than signaling exhaustion.
Volume trends can help identify potential breakouts. For ELTP, the increased volume on upward price movement could be signaling a continued bullish trend or potential for further upside breakouts.
Divergences between volume and price can signal potential reversals. There is no such divergences for ELTP currently.
ELTP "holds several positive signals and is within a strong rising trend." The increasing volume appears to be supporting this bullish outlook.
Higher liquidity (increased volume) is seen as reducing overall risk for the stock.
Sold for a little still think this is a great company
I believe it can be sideward movement for the SP, until another catalyst triggers a breakaway.
Any tech experts here that can chart the behavior?
Shorts are starting to cover end of day. They don’t wanna be short for opening on Monday morning news anytime and one of these days they are going to get caught with their pants down big time. Oh everybody have a good weekend. We’ll see what we can produce next week.
Volume drying up. More sellers. Not a surprise. The long game is clear and we have good indications how this will end.
I do think elite will do well once they get more wins out there.
Phony Longs selling for weekend beer money.
Why don't you ask him?
Elite should break through $0.40 before months end !!!!!!!!!
IB_🤴🏻
One could also use the proceeds of selling all (claimed) shares at .15 to buy an iHub subscription. OR, and I'm not sure if there is bail in regards to iHub jail, but proceeds of selling all (claimed) shares at .15 could also be used for that. So many options!!!
Did you use the proceeds from your sales at 15 cents to buy back in this week?
Thanks for posting
LOL - so, so sad. Buy some shares. You can also read up on the company for relevant timelines. You'll see we are right on track. No lies about it.
I'd buy in at the dips, but it will not be long at these levels. There's 102 days left until the end of the year. How many news releases between now and then? Hopefully about six to eight...most of us are waiting for the next leap. I haven't sold a share yet.
Buying the dips. We are golden. Cat people united we are buying big time.
He basically said the pdufa date won't change. They could have said see you in 6 months but they did the opposite.
My guess based on the qualitative info on this board is that there are approved generics but very little has launched or has API
FDA has pressure to relieve these shortages so I would best guess it's any day from now through November pdufa date
Oxy has a Oct pdufa date. I think anyway. Since purdues lawsuit is on that and the associated patents, can there still be a lawsuit or the approval held if the patent is invalid. Obviously not so what will Purdue and Elite do?
Was also referred back to the patent office for the same reason to get cancelled or removed or whatever they do in this case.
Do you think that is another month from GDUFA date or about month from that conversation, which would mean about now?
Nasrat mentioned that when/if approved, it will be the prioritized drug to manufacturer within the next 4 months. He doesn't know exactly when and gave it within the later part of 2024.
Well, if your looking for first to file, I go to this link
https://www.fda.gov/drugs/drug-and-biologic-approval-and-ind-activity-reports/first-generic-drug-approvals
As far as I know, nobody is allowed to make a Generic Oxycontin,
they may make a similar drug like oxycodone hydrochloride, or such, but they are not allowed to market it as
Generic OxyContin
now, last I heard KNOA is supposed to be making Oxycontin for Purdue,
that is, Purdue is still making the drug, and it's the oddest thing,
the proceeds of the sales under the new name is supposed to go to paying the millions and millions
in lawsuits,
so take that for what it's worth, lol
Dude it's the entire market. Stop looking at things in a vacuum...50bp cut is bearish I suppose. Should have been 25 over the summer.
Question for group. Based on last cc, FDA needed another month to review API source for Vyvanse. Do you think that is another month from GDUFA date or about month from that conversation, which would mean about now?
Second Friday in a row where the volume is inexistent.
I feel very lucky to be in this, I came across the stock randomly and have made $50,000 in a very short period of time. At first my plan was to turn around for a quick profit, but the more I learn about the stock the more I realize it's a hidden gem and a long hold. Wish I'd discovered it sooner, but better late than never! With 500,000 I feel like I will be setting myself up for a comfortable future.
WE were for years at 2-5 cents - this thing will explode without notice soon - your call.
Are you guys buying at these levels? I need 50,000 more shares to reach my target of 500,000, not sure whether to scoop them up at 0.375 or wait a bit longer...
I’ve made close to 800,000 on this stock and that’s after being down close to 100,000 due do buying at the wrong time. I loaded ( we’re talking millions) up at three cents and yes , I did sell at 15 and 25 and 35. I still own 500,000 shares so want the stock to go up.
I’m just nit a cheerleader like most of you. I’ve made my money. You guys bought a few thousand shares so are praying for the lottery to hit. My ticket came in.
And really, I don’t care if you belive me. Just think how much you could have made has you bout MILLIONS at three cents
Geez, Im so sorry your exit was 15 cents
That was just when ELTP started its run up.. it almost hit 42 cents!!
Dont let it bother you too much
If I would have sold my Elite shares for 15 cents, I'll feel extremely defeated,because I'll never recover from that huge loss again.
Better luck next time !!!
What is this finance 101. We need news on the needle movers. If bad news, we drop like a rock. We’re still a penny stock. Nasrat needs to step it up.
Just my opinion
Yup , Best Veh to Invest/ Trade in ,& better way to go.. if Karmella gets installed Roths wont be effected by her ,looking forward to taking distributions from mine in 2025 once BTC peeks
It's a different world here in Canada.
Securities that trade only on OTC markets are not considered qualified investments for TFSAs(tax free savings account) and RRSPs(registered retirement savings plan)
The Canada Revenue Agency (CRA) states that "securities that trade on OTC markets are generally not qualified investments."
However, American Depositary Receipts (ADRs), may be qualified investments if the underlying security is listed on a designated stock exchange. 🙁
Hope you have lots of Tylenol on hand.....💊🤣
https://www.shopify.com/ca/blog/operating-income-vs-net-income
Followers
|
1000
|
Posters
|
|
Posts (Today)
|
7
|
Posts (Total)
|
409358
|
Created
|
03/24/09
|
Type
|
Free
|
Moderators jimr1717 mrwrn2010 NASDAQ2020 IB_ namtae Dr JoeBarducci |
Senior Moderator: IB_
Posted: 7/02/2024
________________________________________________________________________________________________________________
Elite Pharmaceuticals, Inc. |
Website | Location | Employees | Facility | CEO |
www.elitepharma.com | Northvale, New Jersey | 64 | 85,000 sq ft | Nasrat Hakim |
Products & Pipeline | ||||
Drug | Market Size | Status | Competitors | Marketed By |
Adderall IR | 389.8 M | On Market | 15 | Elite |
Adderall XR | 1.56 B | On Market | 10 | Elite & Prasco |
Dantrolene | 6.3 M | On Market | 2 | Elite |
Isradipine | 5.5 M | On Market | 1 | Elite |
Loxapine | 5 M | On Market | 2 | Elite |
Phendimetrazine | 4.5 M | On Market | 4 | Elite |
Trimipramine | 2 M | On Market | 1 | Elite |
Naltrexone | 16 M | On Market | 5 | Precision Dose |
Phentermine Capsules | 7.5 M | On Market | 6 | Precision Dose |
Phentermine Tablets | 40 M | On Market | 8 | Precision Dose |
Vigabatrin | 233.7 M | On Market | 13 | Pyros |
Doxycycline | 85 M | Approved (Discontinued) | 9 | ---------- |
Tylenol with Codeine | 45 M | Approved in Launch Queue | 5 | ---------- |
Dopamine Agonist | 12 M | Filed with FDA - 22 Dec 2022 | ---------- | ---------- |
Methotrexate | 63.4M | On Market | 8 | Elite |
Percocet | 500 M | Approved in Launch Queue | 14 | ---------- |
Norco | 477 M | Approved in Launch Queue | 12 | ---------- |
Methadone | 30 M | Approved in Launch Queue | 8 | ---------- |
OxyContin | 720 M | Filed with FDA - 17 Aug 2023 | ??? | ---------- |
Vyvanse | 5.10 B | Filed with FDA - 21 Dec 2023 | 11 | ---------- |
Concerta | 1.16 B | In Development (Final Stages) | 8 | ---------- |
Financials | ||||
Fiscal Year | Revenue | Change | Net Income | Change |
2019 | 7,568,508 | ---------- | (9,279,321) | ---------- |
2020 | 17,994,639 | +137.76% | (2,240,351) | +75.86% |
2021 | 25,380,749 | +41.05% | 5,088,421 | +327.13% |
2022 | 32,262,117 | +27.11% | 8,898,245 | +74.87% |
2023 | 34,155,114 | +5.87% | 3,561,846 | -59.97% |
2024 | 56,625,128 | +65.79% | 20,108,631 | +464.56% |
2025 Q-1 | 18,803,063 | +109.39% | 3,864,056 | +144.00% |
2025 Q-2 | ||||
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |